- Email: [email protected]
Infant hearing screening program: High-risk factors for hearing loss
104
Abstracts I Early Human Development 47 (1997) 97-109
ment; NIH ConsensusStatement, 19931,an assumption that will not likely be easily attainable. Despite modern technology, the majority of newborns are not screened in hospitals. This suggeststhat in order to implement universal hearing screening, post-discharge sites will be asked to accommodate the testing of the majority of newborn babies. Our advice is: Do not throw away your evoked potential/automated systems;there remains a place now and in the future for such instrumentation. As technology advances,test accuracy will improve with concurrent decreases in cost and time. Most important, whatever technology you are currently employing, continue to screen newborns for hearing loss. If you are currently working with newborns or infants and are not presently engaged in the hearing screening process, initiate programs with the help of your peers or through professional organizations; most are willing to share their experiences in program development. Finally, persist in educating of physicians, health-care providers, and administrators about the importance of early hearing detection and pursue the initiative of Healthy People 2000: National health promotion and diseaseprevention objectives (1990). Infant Hearing Detection Programs: Accountability K-D. Pool, 3401 Amherst, Dallas, TX 75225, USA.
and information
management.
We have explored accountability for II-ID programs and found that we must consider the performance of our programs one infant at a time. We must assure that our processes lead to the desired outcome of ‘if detect, then connect.’ We must build into our programs the recognition that errors will occur and that we must monitor for them and correct them in real-time. We have seen how we can evolve our programs in a fashion that moves ever closer to fulfilling our responsibility as stewardsof optimizing quality and cost. We have seen that the standards that we apply to our IHD programs can be derived from the program goals and designs themselves rather than from external artificial sources.We have also seen that this daunting task can be facilitated by automation. Infant hearing screening program: High-risk factors for hearing loss. M.V. Feiner, K.M. Pardue, M.J.M. Raffin, G.J. Matz, OtolaryngoL / Head / Neck Surg. Dept., Loyola University Medical Center, 2160 South First Ave., Maywood, IL 40153, USA.
It is important to identify early risk factors for hearing loss because there are significant advantages of early identification for hearing improvement and significant consequences for late identification of hearing impairment. A great deal of discussion has evolved as to which children up to age five should be tested and when the testing should occur. Various screening techniques have been developed and these are important for the direction of future research in the diagnosis and management of hearing impairment in infants and children. Urinary pregnanetriol-3-glncuronide excretion in neonates and the use of urinary pregnanetriol-3-glucuronide/creatinine ratio in differentiating 21.bydroxyylase deficiency. S. Saisho, Y. Yang, T. Toyoura, K. Shimozawa, H. Takei, M. Matsu-
Abstracts I Early Human Development 47 (1997) 97-109
ment; NIH ConsensusStatement, 19931,an assumption that will not likely be easily attainable. Despite modern technology, the majority of newborns are not screened in hospitals. This suggeststhat in order to implement universal hearing screening, post-discharge sites will be asked to accommodate the testing of the majority of newborn babies. Our advice is: Do not throw away your evoked potential/automated systems;there remains a place now and in the future for such instrumentation. As technology advances,test accuracy will improve with concurrent decreases in cost and time. Most important, whatever technology you are currently employing, continue to screen newborns for hearing loss. If you are currently working with newborns or infants and are not presently engaged in the hearing screening process, initiate programs with the help of your peers or through professional organizations; most are willing to share their experiences in program development. Finally, persist in educating of physicians, health-care providers, and administrators about the importance of early hearing detection and pursue the initiative of Healthy People 2000: National health promotion and diseaseprevention objectives (1990). Infant Hearing Detection Programs: Accountability K-D. Pool, 3401 Amherst, Dallas, TX 75225, USA.
and information
management.
We have explored accountability for II-ID programs and found that we must consider the performance of our programs one infant at a time. We must assure that our processes lead to the desired outcome of ‘if detect, then connect.’ We must build into our programs the recognition that errors will occur and that we must monitor for them and correct them in real-time. We have seen how we can evolve our programs in a fashion that moves ever closer to fulfilling our responsibility as stewardsof optimizing quality and cost. We have seen that the standards that we apply to our IHD programs can be derived from the program goals and designs themselves rather than from external artificial sources.We have also seen that this daunting task can be facilitated by automation. Infant hearing screening program: High-risk factors for hearing loss. M.V. Feiner, K.M. Pardue, M.J.M. Raffin, G.J. Matz, OtolaryngoL / Head / Neck Surg. Dept., Loyola University Medical Center, 2160 South First Ave., Maywood, IL 40153, USA.
It is important to identify early risk factors for hearing loss because there are significant advantages of early identification for hearing improvement and significant consequences for late identification of hearing impairment. A great deal of discussion has evolved as to which children up to age five should be tested and when the testing should occur. Various screening techniques have been developed and these are important for the direction of future research in the diagnosis and management of hearing impairment in infants and children. Urinary pregnanetriol-3-glncuronide excretion in neonates and the use of urinary pregnanetriol-3-glucuronide/creatinine ratio in differentiating 21.bydroxyylase deficiency. S. Saisho, Y. Yang, T. Toyoura, K. Shimozawa, H. Takei, M. Matsu-